Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
Handling and Storage Recommendations Store sealed at 20 C, protected from light and moisture
Is it because of injection
COA / Lab results Evidence: Preclinical Pros Selective, membrane-permeable NNMT inhibitor Raises intracellular NAD+ and SAM by blocking the methylation sink Reduced weight and fat mass in diet-induced obese mice Activates sirtuin pathways associated with metabolic health Cons Evidence entirely preclinical (cell/mouse)
US$ 26.93
US$ 21.16
US$ 29.75
